Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Skin drug delivery using lipid vesicles: A starting guideline for their development
Lipid vesicles can provide a cost-effective enhancement of skin drug absorption when
vesicle production process is optimised. It is an important challenge to design the ideal …
vesicle production process is optimised. It is an important challenge to design the ideal …
Overcoming barriers by local drug delivery with liposomes
Localized or topical administration of drugs may be considered as a potential approach for
overcoming the problems caused by the various biological barriers encountered in drug …
overcoming the problems caused by the various biological barriers encountered in drug …
Subcutaneous drug delivery from nanoscale systems
L Tomasini, M Ferrere, J Nicolas - Nature Reviews Bioengineering, 2024 - nature.com
Various types of nanoscale drug delivery systems (DDSs) have been developed for
therapeutic and/or diagnostic applications. However, most systems have been designed for …
therapeutic and/or diagnostic applications. However, most systems have been designed for …
[HTML][HTML] Injectable lipid-based depot formulations: where do we stand?
L Rahnfeld, P Luciani - Pharmaceutics, 2020 - mdpi.com
The remarkable number of new molecular entities approved per year as parenteral drugs,
such as biologics and complex active pharmaceutical ingredients, calls for innovative and …
such as biologics and complex active pharmaceutical ingredients, calls for innovative and …
Probing the mechanism of bupivacaine drug release from multivesicular liposomes
The mechanism of drug release from complex dosage forms, such as multivesicular
liposomes (MVLs), is complex and oftentimes sensitive to the release environment. This …
liposomes (MVLs), is complex and oftentimes sensitive to the release environment. This …
Lipid-based carriers for the delivery of local anesthetics
Introduction: There is a clinical need for pharmaceutical dosage forms devised to prolong
the acting time of local anesthetic (LA) agents or to reduce their toxicity. Encapsulation of LA …
the acting time of local anesthetic (LA) agents or to reduce their toxicity. Encapsulation of LA …
Insecticidal activity of Tagetes erecta and Tagetes patula extracts and fractions free and microencapsulated
PC e Santos, FO Granero, JLB Junior… - Biocatalysis and …, 2022 - Elsevier
This study aimed to characterize T. erecta and T. patula extracts, develop a technique of
encapsulation, evaluate insecticidal activity of extracts, fractions and liposomes containing …
encapsulation, evaluate insecticidal activity of extracts, fractions and liposomes containing …
PEGylated Nanoliposomal Doxorubicin Conjugated with Specific TREM2 Peptides for Glioma‐Targeting Therapy
H Li, D Xu, W Cai, J Liu, Z Bing… - Advanced Healthcare …, 2025 - Wiley Online Library
PEGylated liposomes can deliver anti‐cancer drugs to brain tumors, and achieve enhanced
permeability and retention effects. Triggering receptor expressed on myeloid cells 2 …
permeability and retention effects. Triggering receptor expressed on myeloid cells 2 …
Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers …
Y Yang, D Qiu, Y Liu, L Chao - Drug Design, Development and …, 2019 - Taylor & Francis
Purpose Hyaluronic acid-poly (ethylene glycol)-distearoyl phosphoethanolamine (HA-PEG-
DSPE) modified and tocopheryl polyethylene glycol 1000 succinate (TPGS) contained …
DSPE) modified and tocopheryl polyethylene glycol 1000 succinate (TPGS) contained …
[HTML][HTML] Preparation of ropivacaine-loaded mesoporous bioactive glass microspheres and evaluation of their efficacy for sciatic nerve block
QR Liu, YC Dai, LJ Ji, MD Gong, X Li, J Fang… - Journal of Drug Delivery …, 2020 - Elsevier
Local anesthetics are mainly used for regional anesthesia and analgesia. However, the
duration of action is limited in clinical applications. In the present study, we developed a …
duration of action is limited in clinical applications. In the present study, we developed a …